The Australian regulatory model for supplements/complementary medicines has been built over many years. In this webinar, Carl Gibson provides an introduction to the latest changes introduced by the government in cooperation with the association, to ensure an appropriate framework for future product innovation. This addresses not just the pathways for new ingredients to access the market, but also the conditions around exclusivity and data protection.
Chief Executive Officer, Complementary Medicines Australia
Carl Gibson MSc is the Chief Executive Officer of Complementary Medicines Australia. He was appointed to the position in September 2013, having previously been the Head of Brand & Communications at Blackmores Group.
Complementary Medicines Australia is the peak body for a $5.6 billion industry and represents over 150 members from across the whole supply chain. In the last five years exports of Australian complementary medicines have grown from near zero to a $1 billion success story.
Carl started his career in the UK as a public servant, before joining the Conservative Party as a media and political adviser. He served under the then UK Prime Minister John Major from 1990 to 1994.
His career spans over 25 years and he has specialised in Regulation, Public Policy and Campaign Communications. He was part of the senior leadership teams that transformed UK electricity generator British Energy and the USA healthcare software company Allscripts.
Carl holds a Master of Science in Corporate Governance and is a Director and Public Officer of Complementary Medicines Australia; Chair & Director of ‘Find My Appointment’ a joint industry venture and serves on the Ministerial Board on Therapeutic Goods & The Therapeutic Goods Administration Consultative Committee, the Advisory Board for NICM Health Research Institute, and contributes to the course work of the National Institute of Integrative Medicine.
